Investigating how protein processes affect blood vessel health in early pulmonary arterial hypertension.
Ubiquitination and Endothelial Fibrosis in Early Pulmonary Arterial Hypertension
This study is looking at how a process called ubiquitination affects the thickening of blood vessels in the lungs, which can lead to early pulmonary arterial hypertension (PAH) and heart problems, with the goal of finding new ways to help patients feel better.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham and Women's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10842357 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of ubiquitination in the development of endothelial fibrosis, which is a key factor in early pulmonary arterial hypertension (PAH). The project aims to explore the biochemical processes that lead to vascular remodeling and dysfunction in the lungs, potentially leading to heart failure. Through a combination of laboratory experiments and clinical insights, the research seeks to identify early therapeutic targets that could improve patient outcomes. The principal investigator will receive mentorship from leading experts in the field to ensure a comprehensive approach to the problem.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with early-stage pulmonary arterial hypertension.
Not a fit: Patients with advanced pulmonary arterial hypertension or those who do not have a diagnosis of PAH may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve the health and longevity of patients with early pulmonary arterial hypertension.
How similar studies have performed: Previous research has shown promising results in targeting similar biochemical pathways in vascular diseases, indicating potential for success in this area.
Where this research is happening
Boston, United States
- Brigham and Women's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Wertheim, Bradley — Brigham and Women's Hospital
- Study coordinator: Wertheim, Bradley
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.